Trial Outcomes & Findings for Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program (NCT NCT02087670)
NCT ID: NCT02087670
Last Updated: 2016-03-10
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
42 participants
Primary outcome timeframe
8 weeks
Results posted on
2016-03-10
Participant Flow
Outpatient with heart failure were recruited since March 2005 to January 2008.
Participant milestones
| Measure |
Controlled, Supervised Exercise Protocol
controlled, supervised exercise protocol within a cardiac rehabilitation program
controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
|
Community Based Exercise
educational program and not supervises exercise program
|
|---|---|---|
|
Overall Study
STARTED
|
20
|
22
|
|
Overall Study
COMPLETED
|
17
|
20
|
|
Overall Study
NOT COMPLETED
|
3
|
2
|
Reasons for withdrawal
| Measure |
Controlled, Supervised Exercise Protocol
controlled, supervised exercise protocol within a cardiac rehabilitation program
controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
|
Community Based Exercise
educational program and not supervises exercise program
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
3
|
2
|
Baseline Characteristics
Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program
Baseline characteristics by cohort
| Measure |
Controlled, Supervised Exercise Protocol
n=20 Participants
controlled, supervised exercise protocol within a cardiac rehabilitation program
controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
|
Community Based Exercise
n=22 Participants
educational program and not supervises exercise program
|
Total
n=42 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
20 Participants
n=5 Participants
|
22 Participants
n=7 Participants
|
42 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
57 years
STANDARD_DEVIATION 14 • n=5 Participants
|
55 years
STANDARD_DEVIATION 13 • n=7 Participants
|
55 years
STANDARD_DEVIATION 11 • n=5 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
21 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
21 Participants
n=5 Participants
|
|
Region of Enrollment
Colombia
|
20 participants
n=5 Participants
|
22 participants
n=7 Participants
|
42 participants
n=5 Participants
|
|
Natriuretic Brain pro-peptide
|
429 pg/ml
n=5 Participants
|
278 pg/ml
n=7 Participants
|
386 pg/ml
n=5 Participants
|
|
Oxygen Consumption
|
832 ml/min
STANDARD_DEVIATION 228 • n=5 Participants
|
811 ml/min
STANDARD_DEVIATION 229 • n=7 Participants
|
821 ml/min
STANDARD_DEVIATION 226 • n=5 Participants
|
PRIMARY outcome
Timeframe: 8 weeksOutcome measures
| Measure |
Controlled, Supervised Exercise Protocol
n=19 Participants
controlled, supervised exercise protocol within a cardiac rehabilitation program
controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
|
Community Based Exercise
n=22 Participants
educational program and not supervises exercise program
|
|---|---|---|
|
Natriuretic Brain Pro-peptid
|
312 pg/ml
Interval 24.0 to 2312.0
|
200 pg/ml
Interval 14.0 to 3481.0
|
SECONDARY outcome
Timeframe: 8 weeksOutcome measures
| Measure |
Controlled, Supervised Exercise Protocol
n=17 Participants
controlled, supervised exercise protocol within a cardiac rehabilitation program
controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
|
Community Based Exercise
n=20 Participants
educational program and not supervises exercise program
|
|---|---|---|
|
Oxygen Consumption
|
831 ml/min
Standard Deviation 250
|
919 ml/min
Standard Deviation 298
|
Adverse Events
Controlled, Supervised Exercise Protocol
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Community Based Exercise
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place